KOFA Healthcare
VC Fund
West Lafayette, United States
KOFA Healthcare is a VC fund in West Lafayette focused on Health Care and Medical Device. KOFA Healthcare Investments is a healthcare investment firm investing in early-stage life sciences startups in the areas of orthopedics and sports medicine, maternal health, and obesity or diabetes. It was founded in 2016 and is headquartered in West Lafayette, Indiana.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries KOFA Healthcare invests in
Stages KOFA Healthcare invests in
Countries KOFA Healthcare invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Renee Masi
|
|||
Investment Focus
Industry
- Health Care 8 (53%)
- Medical Device 7 (47%)
- Medical 6 (40%)
- Biotechnology 3 (20%)
- Health Diagnostics 3 (20%)
Stage
- Series A 6 (40%)
- Series B 3 (20%)
- Pre-Seed 1 (7%)
- Series C 1 (7%)
- Private Equity 1 (7%)
Country
- United States 10 (67%)
- Switzerland 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Renee Masi
Senior Managing Director
|
Senior Managing Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Axon Therapies
|
Develops a healthcare device with a neuromodulation approach to treat heart failure. | $32M / Series A / Sep 25, 2025 | |
illumicell AI
|
illumicell AI combines patented AI algorithms and proprietary microscopy technology to test 50x faster, 20x more effectively, empowering every healthcare provider at the point of care – not just fertility clinics – with accessible, scalable fertility diagnostics. | $2M / Pre-Seed / Apr 10, 2025 | |
Zafrens
|
Zafrens specializes in developing tools and generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States. | Series A / Feb 04, 2025 | |
Aria CV
|
Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, formerly Fellows at the University of Minnesota’s Medical Devices Center. Aria has an exclusive license to certain patents from the University of Minnesota. Aria CV’s device has the potential to improve outcomes by reducing the workload on the right side of the heart. | Series B / Sep 30, 2024 | |
CorFlow Therapeutics
|
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients. | $48.5M / Series B / Sep 10, 2024 | |
Venova Medical
|
Venova Medical develops vascular access systems for patients requiring renal replacement therapy. It addresses patient level and system barriers for access creation while simultaneously providing quickly functioning access with less need for intervention. The company was founded in 2018 and is headquartered in Los Gatos, California. | $30M / Series B / Sep 04, 2024 | |
Axena Health
|
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | $9.4M / Series A / Jun 04, 2024 | |
|
Zafrens
|
Zafrens specializes in developing tools and generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States. | $23M / Series A / Dec 11, 2023 | |
|
illumicell AI
|
illumicell AI combines patented AI algorithms and proprietary microscopy technology to test 50x faster, 20x more effectively, empowering every healthcare provider at the point of care – not just fertility clinics – with accessible, scalable fertility diagnostics. | $300K / Pre-Seed / Oct 09, 2023 | |
|
Axena Health
|
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | $1.8M / Private Equity / Aug 08, 2023 | |
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does KOFA Healthcare invest in?
KOFA Healthcare invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact KOFA Healthcare?
Public channels for KOFA Healthcare include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at KOFA Healthcare?
The team at KOFA Healthcare includes Renee Masi (Senior Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
